Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Hosted on MSN4h
FTC's Khan defends her record on "60 Minutes"Lina Khan, chair of the Federal Trade Commission, defended her agency's aggressive antitrust record in an interview on "60 ...
In an interview with 60 Minutes, the Federal Trade Commission head said the agency believes it has the authority to ban ...
FTC Chair Lina Khan said in a "60 Minutes" interview that hundreds of acquisitions by Big Tech players like Facebook led to ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback